MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3)-Reference-Cited by-同舟云学术

MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3)

Published:2020-03-30 Issue:4 Volume:30 Page:732-745
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:Brain Pathol

Author:

Kanchan Ranjana K.¹,Perumal Naveenkumar¹,Atri Pranita¹,Chirravuri Venkata Ramakanth¹,Thapa Ishwor²,Klinkebiel David L.¹,Donson Andrew M.³,Perry Deborah⁴,Punsoni Michael⁵,Talmon Geoffrey A.⁵,Coulter Donald W.⁶,Boue’ Daniel R.⁷,Snuderl Matija⁸,Nasser Mohd. W.¹,Batra Surinder K.¹,Vibhakar Rajeev³,Mahapatra Sidharth¹⁹^ORCID

Affiliation:

1. Department of Biochemistry University of Nebraska Medical Center Omaha NE

2. School of Interdisciplinary Informatics University of Nebraska at Omaha Omaha NE

3. Morgan Adams Pediatric Brain Tumor Research Program University of Colorado School of Medicine Denver CO

4. Department of Pathology Children’s Hospital and Medical Center Omaha NE

5. Department of Pathology University of Nebraska Medical Center Omaha NE

6. Department of Hematology/Oncology University of Nebraska Medical Center Omaha NE

7. Department of Pathology and Laboratory Medicine Nationwide Children's Hospital and the Ohio State University Columbus OH

8. Department of Pathology New York University Langone Health New York NY

9. Department of Pediatrics University of Nebraska Medical Center Omaha NE

Funder

National Cancer Institute